User menu

Anti-ige-induced and Anti-iga-induced Eosinophil Migration in Atopics and Healthy-volunteers

Bibliographic reference Rihoux, JP. ; Melac, M. ; Henocq, E.. Anti-ige-induced and Anti-iga-induced Eosinophil Migration in Atopics and Healthy-volunteers.1990 ANNUAL MEETING OF THE EUROPEAN ACADEMY OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY (GLASGOW(Scotland), Jun, 1990). In: Clinical and Experimental Allergy, Vol. 20, p. 11-18 (1990)
Permanent URL
  1. Ishizaka Kimishige, Jardieu Paula, Akasaki Moriaki, Iwata Makoto, T Cell Factors Involved in the Regulation of the IgE Synthesis, 10.1159/000234233
  2. Banchereau J, Med Hyg, 46, 960 (1988)
  3. Ishizaka Kimishige, Regulation of the IgE Antibody Response, 10.1159/000234739
  4. Metzger H., Blank U., Kinet J.-P., Kochan J., Ra C., Rivera J., White K., Emerging Picture of the Receptor with High Affinity for IgE, 10.1159/000234740
  5. Delespesse G., Sarfati M., Hofstetter H., Frost H., Kilchherr E., Suter U., Human FcεR II and IgE-Binding Factors, 10.1159/000234741
  6. Capron M, J Immunol, 232, 462 (1984)
  7. Capron Monique, Tomassini Margherita, Torpier Gérard, Kusnierz Jean-Pierre, MacDonald Susan, Capron André, Selectivity of Mediators Released by Eosinophils, 10.1159/000234748
  8. Joseph M., Tonnel A. B., Capron A., Dessaint J. P., The interaction of IgE antibody with human alveolar macrophages and its participation in the inflammatory processes of lung allergy, 10.1007/bf01978766
  9. Bruynzeel-Koomen C., Dermatologica, 172, 181 (1986)
  10. Yagi Y, J Immunol, 91, 83 (1963)
  11. Ishizcika K, J Immunol, 98, 490 (1967)
  12. Kitani S, Ann Allergy, 55, 612 (1985)
  13. GUTT L, GREENBERGER P, LIOTTA J, Serum IgA antibodies to in various stages of allergic bronchopulmonary aspergillosis, 10.1016/0091-6749(86)90120-x
  14. GREENBERGER P, SMITH L, HSU C, ROBERTS M, LIOTTA J, Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: Divergent responses of antigen-specific antibodies and total IgE, 10.1016/0091-6749(88)90995-5
  15. APTER A, GREENBERGER P, LIOTTA J, ROBERTS M, Fluctuations of serum IgA and its subclasses in allergic bronchopulmonary aspergillosis, 10.1016/0091-6749(89)90422-3
  16. Platts-Mills TAB, J Clin Invest, 57, 1041 (1976)
  17. Chapman MD, Clin Exp Immunol, 34, 126 (1978)
  18. Fanger MW, Proc Natl Acad Sci U.S.A, 77, 3640 (1980)
  19. Shen Li, Fanger Michael W., Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes, 10.1016/0008-8749(81)90435-4
  20. Gauldie Jack, Richards Carl, Lamontagne Louis, Fc receptors for IgA and other immunoglobulins on resident and activated alveolar macrophages, 10.1016/0161-5890(83)90044-5
  21. Johnson KJ, J Clin Invest, 74, 358 (1984)
  22. Abu-Ghazaleh RI, J Immunol, 142, 2393 (1989)
  23. Yokota T, Proc Nail Acad Sci U.S.A, 84, 7388 (1987)
  24. Coffman RL, J Immunol, 139, 3685 (1987)
  25. Monchy JGR, Am Rev Respir Dis, 131, 373 (1986)
  27. AYARS G, ALTMAN L, GLEICH G, LOEGERING D, BAKER C, Eosinophil- and eosinophil granule-mediated pneumocyte injury, 10.1016/0091-6749(85)90781-x
  28. O'Donnell M. C., Activation of basophil and mast cell histamine release by eosinophil granule major basic protein, 10.1084/jem.157.6.1981
  29. GLEICH G, Chapter 4 Eosinophils, basophils, and mast cells, 10.1016/0091-6749(89)90144-9
  30. DURHAM S, LOEGERING D, DUNNETTE S, GLEICH G, KAY A, Blood eosinophils and eosinophil-derived proteins in allergic asthma, 10.1016/0091-6749(89)90391-6
  31. Eidinger E, Nature, 4855, 683 (1962)
  32. Hu F, J Invest Dermatol, 409 (1962)
  33. ATKINS P, GREEN G, ZWEIMAN B, Histologic studies of human skin test responses to ragweed, compound 48/80, and histamine, 10.1016/0091-6749(73)90128-0
  34. Bryant DH, Clin Allergy, 7, 211 (1977)
  35. Pipkorn Ulf, Karisson Göran, Enerback Lennart, The cellular response of the human allergic mucosa to natural allergen exposure, 10.1016/0091-6749(88)90143-1
  36. Bonini Sergio, Bonini Stefane, Vecchione Aldo, Nairn Daniele M., Allansmith Mathea R., Balsano Francesco, Inflammatory changes in conjunctival scrapings after allergen provocation in humans, 10.1016/0091-6749(88)90020-6
  37. Pelikan Z., Pelikan-Fillpek M., Cytologic changes in the nasal secretions during the immediate nasal response, 10.1016/0091-6749(88)90150-9
  39. Rihoux J-P, Ann Allergy, 59, 235 (1987)
  40. Venge Per, Håkansson Lena, Peterson Christer G.B., Eosinophil Activation in Allergic Disease, 10.1159/000234219
  41. Prin Lionel, Capron Monique, Tonnel André-Bernard, Bletry Olivier, Capron André, Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of Hypereosinophilia, 10.1159/000234893
  42. Lee T-C, J Biol Chem, 259, 5526 (1984)
  43. Walsh G.M., Moqbel R., Wardlaw A.J., Kay A.B., In Vitro Effects of Chemotactic Factors on Eosinophil Fc and Complement Receptor Expression, 10.1111/j.1442-200x.1987.tb00358.x
  44. BASCOM R, PIPKORN U, PROUD D, DUNNETTE S, GLEICH G, LICHTENSTEIN L, NACLERIO R, Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: Effect of systemic corticosteroids and relationship to eosinophil influx, 10.1016/0091-6749(89)90418-1
  45. SHULT P, GRAZIANO F, BUSSE W, Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis, 10.1016/0091-6749(86)90414-8
  46. Fukuda T, Am Rev Respir Dis, 132, 981 (1985)
  47. Venge Per, Dahl Ronald, Peterson Christer G.B., Eosinophil Granule Proteins in Serum after Allergen Challenge of Asthmatic Patients and the Effects of Anti-Asthmatic Medication, 10.1159/000234690
  48. Fadel R, Clin Allergy, 17, 373 (1987)
  49. Michel Laurence, De Vos Christine, Rihoux Jean-Pierre, Burtin Claude, Benveniste Jacques, Dubertret Louis, Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin, 10.1016/0091-6749(88)90058-9
  50. CHARLESWORTH E, KAGEYSOBOTKA A, NORMAN P, LICHTENSTEIN L, Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction, 10.1016/0091-6749(89)90104-8
  51. Van Neste D, Skin Pharmacol, 2, 93 (1989)
  52. Henocq E, Allergol Immunol Clin, 2, 302 (1987)
  53. Juhlin L, Acta Dermat Venereol, 70, 151 (1990)
  54. Fadel R, Health Sci Rev, 3, 11 (1988)
  55. Rihoux J-P., The allergic reaction
  56. Ishizaka K, J Immunol, 95, 197 (1965)
  57. Heremans JF, J Immunol, 91, 11 (1963)
  58. Boackle Robert J., Pruitt Kenneth M., Mestecky Jiri, The interactions of human complement with interfacially aggregated preparations of human secretory IgA, 10.1016/0019-2791(74)90245-6
  59. Iida Kyoko, Fujita Teizo, Inai Shinya, Sasaki Makoto, Kato Taiji, Kobayashi Kunihiko, Complement fixing abilities of IgA myeloma protiens and their fragments: The activation of complement through the classical pathway, 10.1016/0019-2791(76)90195-6
  60. Pfaffenbach G., Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes, 10.1084/jem.155.1.231
  61. Griffis JM., Ann Acad Sci, 409, 696 (1983)
  62. Siraganian RP, J Clin Immunol, 116, 639 (1976)
  63. Schwartz LB, J Clin Immunol, 130, 1891 (1983)
  64. Yancey KB, J Clin Invest, 75, 486 (1985)
  65. Lepow IH, Am J Pathol, 61, 13 (1970)
  66. Williams T. J., Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a, 10.1084/jem.153.1.136